Global Rapid Influenza Diagnostic Test (RIDT) Market Size, Status and Forecast 2019-2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: World Rapid Influenza Diagnostic Test (RIDT) Market


Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.The classification of Rapid Influenza Diagnostic Test (RIDT) includes Conventional RIDT and Digital RIDTs. The proportion of digital RIDTs in 2018 is about 53.35% of revenue.Rapid Influenza Diagnostic Test (RIDT) is application in hospital, POCT and others. The most of Rapid Influenza Diagnostic Test (RIDT) is used in hospital, and the market share of that is about 63.97% in 2018.North America is the largest consumption place, with a consumption market share nearly 53.65% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 26.27% in 2018.Market competition is intense. BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics) are the leaders of the industry, and have been formed in the monopoly position in the industry.In 2018, the global Rapid Influenza Diagnostic Test (RIDT) market size was 973.1 million US$ and it is expected to reach 1751.7 million US$ by the end of 2025, with a CAGR of 8.7% during 2019-2025.This report focuses on the global Rapid Influenza Diagnostic Test (RIDT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rapid Influenza Diagnostic Test (RIDT) development in United States, Europe and China

Market Segmentation, Outlook & Viewpoint: World Rapid Influenza Diagnostic Test (RIDT) Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Digital RIDTs
Conventional RIDT

In 2018, Digital RIDTs accounted for a major share of 55.36% the global Rapid Influenza Diagnostic Test (RIDT) market. And this product segment is poised to reach 1039.09 million US$ by 2025 from 588.84 million US$ in 2018

Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Hospitals
POCT
Others

In Rapid Influenza Diagnostic Test (RIDT) market, the Hospitals holds an important share in terms of application, and it is expected to reach revenue of by 2025, at a CAGR of 8.37% during 2019 and 2025

Top Companies & Key Players: World Rapid Influenza Diagnostic Test (RIDT) Market


BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics

Key Insights Covered: World Rapid Influenza Diagnostic Test (RIDT) Market
1.  North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Rapid Influenza Diagnostic Test (RIDT) industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Rapid Influenza Diagnostic Test (RIDT) industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Rapid Influenza Diagnostic Test (RIDT) industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Rapid Influenza Diagnostic Test (RIDT) industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Rapid Influenza Diagnostic Test (RIDT) industry.

Research Methodology: Global Rapid Influenza Diagnostic Test (RIDT) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.